Nonalcoholic steatohepatitis: a possible side effect of atypical antipsychotics
Haberfellner, E.M.; Honsig, T.
Journal of Clinical Psychiatry 64(7): 851
2003
ISSN/ISBN: 0160-6689 PMID: 12934993 Document Number: 555084
Document emailed within 1 workday
Related Documents
Dai, X.-w.; Chen, Z.-y.; Yan, M.-x.; He, B.-h. 2015: Experimental study on intervention effect of Grifola frondosa on nonalcoholic steatohepatitis Zhongguo Zhong Yao Za Zhi 40(9): 1808-1811Castellano Tortajada, G. 1999: Nonalcoholic steatohepatitis Gastroenterologia y Hepatologia 22(Suppl 1): 13-19
Jacquemin, G. 2003: Nonalcoholic steatohepatitis: a review Revue Medicale de Liege 58(3): 147-154
Chavez-Tapia, N.C.; Barrientos-Gutierrez, T.; Uribe, M. 2007: Pioglitazone in nonalcoholic steatohepatitis New England Journal of Medicine 356(10): 1067-1068; Author Reply 1068-1069
Bürgi, A.-C.; Dufour, J.-F.ço. 2012: Treatment of nonalcoholic steatohepatitis La Revue du Praticien 62(10): 1425-1427
Ishii, H. 2006: Nonalcoholic steatohepatitis: a brief review on its concept Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1021-1024
Eivindson, M.V.; Hamilton-Dutoit, S.; Grønbaek, H. 2003: Nonalcoholic steatohepatitis. Three case reports Ugeskrift for Laeger 165(11): 1118-1120
Itoh, S.; Yougel, T.; Kawagoe, K. 1987: Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis American Journal of Gastroenterology 82(7): 650-654
Spahr, L.; Hadengue, A. 2005: Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management Revue Medicale Suisse 1(31): 2032-2034
Gutkowski, K.; Gutkowska, D.; Partyka, M. 2006: Nonalcoholic steatohepatitis--current treatment options Przeglad Lekarski 63(2): 91-94
Bencheqroun, R.; Duvoux, C.; Luciani, A.; Zafrani, E-Serge.; Dhumeaux, D. 2004: Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis Gastroenterologie Clinique et Biologique 28(5): 497-499
Morita, Y.; Ueno, T.; Sasaki, N.; Tateishi, Y.; Nagata, E.; Kage, M.; Sata, M. 2005: Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes Hepato-Gastroenterology 52(65): 1338-1343
Ataseven, H.; Yildirim, M.H.; Yalniz, M.; Bahcecioglu, I.H.; Celebi, S.; Ozercan, I.H. 2005: The value of ultrasonography and computerized tomography in estimating the histopathological severity of nonalcoholic steatohepatitis Acta Gastro-Enterologica Belgica 68(2): 221-225
Yuan, L.; Hanlon, C.L.; Terrault, N.; Alqahtani, S.; Tamim, H.; Lai, M.; Saberi, B. 2022: Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States American Journal of Gastroenterology 117(3): 433-444
Selezneva, K.S.; Isakov, V.A.; Sentsova, T.B.; Kirillova, O.O. 2014: An analysis of the efficacy of low-calorie and isocaloric diets in obese patients with nonalcoholic steatohepatitis Voprosy Pitaniia 83(5): 72-78
Sasaki, N.; Ueno, T.; Morita, Y.; Nagata, E.; Sata, M. 2006: Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH) Hepato-Gastroenterology 53(71): 678-681
Khukhlina, O.S.; Antoniv, A.A.; Mandryk, O.Y.; Hryniuk, O.Y.е; Kovalenko, S.V.; Drozd, V.Y.; Kotsiubiichuk, Z.I. 2018: Clinical and pathogenetic features of nonalcoholic steatohepatitis for comorbidity with bronchial asthma on the background of obesity Wiadomosci Lekarskie 71(2 Part 1): 376-379
Lesmana, C.R.; Lesmana, L.A.; Akbar, N.; Gani, R.A.; Simandjuntak, W.; Oemardi, M.; Soejono, C.H.; Marwoto, W.; Juwono, V. 2009: Clinical picture, insulin resistance, and adipocytokines profiles of nonalcoholic steatohepatitis (NASH) patients in Indonesia Acta Medica Indonesiana 41(1): 6-10
Pirvulescu, I.; Gheorghe, L.; Csiki, I.; Becheanu, G.; Dumbravă, M.; Fica, S.; Martin, S.; Sarbu, A.; Gheorghe, C.; Diculescu, M.; Copăescu, C. 2012: Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery Chirurgia 107(6): 772-779
Armer, R.; Miller, D.J. 2000: Recent advances in atypical antipsychotics Current Opinion in Investigational Drugs 1(4): 481-493